Neurodegenerative diseases encompass a wide range of conditions that result from progressive damage to cells and nervous system connections that are essential for mobility, coordination, strength, sensation, and cognition. Neurodegenerative diseases affect millions of people worldwide and represent a major threat to human health.
These age-dependent disorders are becoming increasingly prevalent as a result of the aging population. Parkinson’s Disease affects approximately 100,000 Canadians with approximately 6,600 new cases being diagnosed each year and Valeo Pharma is determined to help.
The first Parkinson’s Disease (PD) treatment in Canada since 2006, providing relief of symptoms during the off-phase in dopamine treated patients.